The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer

Over 300,000 patients develop squamous cell carcinoma of the head and neck (HNSCC) worldwide with 25-30% of patients ultimately dying from their disease. Currently, molecular biomarkers are not used in HNSCC but several genes have been identified including mutant TP53 (mutp53) Our recent work has id...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Coaxum, Sonya D., Tiedeken, Jessica, Garrett-Mayer, Elizabeth, Myers, Jeffrey, Rosenzweig, Steven A., Neskey, David M.
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2017
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5410280/
https://ncbi.nlm.nih.gov/pubmed/28160562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14967
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items